Organisation paid for research Program year 2025 Source: CMS Open Payments

Washington University Division

Neither a doctor nor a teaching hospital

Research payments

$100,778

12 payments

Through program year 2025, Washington University Division is reported as receiving $100,778 in research payments, across 12 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$97,614	10
2024	Research	$544	1
2023	Research	$2,620	1

Breakdown

Who paid Research payments · program years 2023–2025

Sanofi US Services Inc. $100,778 12 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 2b, Multi-national, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Followed by a Long-term Extension to Evaluate the Efficacy and Safety of SAR442970 in Adult Participants With Moderate to Severe Ulcerative Colitis $33,126 1 payment
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR442970 in Adults With Moderate to Severe Crohn's Disease $33,126 1 payment
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy $12,109 2 payments
Fabry Disease Registry Protocol $12,002 4 payments
A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus $7,387 2 payments
Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213 $2,620 1 payment
Pompe Disease Registry $408 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.